Yosef T, Ibrahim WA, Matboli M, Swilam AA, El-Nakeep S. New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study . World J Hepatol 2021; 13(12): 2137-2149 [PMID: 35070014 DOI: 10.4254/wjh.v13.i12.2137]
Corresponding Author of This Article
Sarah El-Nakeep, MD, Associate Professor, Gastroenterology and Hepatology Unit, Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Ramsees Street, Cairo 11591, Egypt. firstname.lastname@example.org
Checklist of Responsibilities for the Scientific Editor of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 6 Clinical and radiological characteristics of hepatocellular carcinoma lesions.
mean ± SD
6.76 ± 1.44
Stage A (early)
Stage D (late)
Average tumor size
> 3 cm
< 3 cm
BCLC: Barcelona Clinic Liver Cancer; SD: Standard deviation.
Citation: Yosef T, Ibrahim WA, Matboli M, Swilam AA, El-Nakeep S. New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study . World J Hepatol 2021; 13(12): 2137-2149